Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC

Lillian Lim, Hung Bui, Olivia Farrelly, Jisheng Yang, Li Li, David Enis, Wanshu Ma, Mei Chen, Guillermo Oliver, John D. Welsh, Mark L. Kahn

Blood (2019) 134 (20): 1764–1775.

https://doi.org/10.1182/blood.2019001736

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Pomalidomide Reduces Bleeding and Alters Expression of Angiogenesis-Related Proteins in Patients with Hereditary Hemorrhagic Telangiectasia

Shadi Swaidani, MD PhD, Suman Kundu, MBA, Mohamed Samour, MBBS, Bernard Silver, MD, Joseph Parambil, MD, Sonia Thomas, DrPH, Keith R McCrae, MD

Blood (2019) 134 (Supplement_1): 5761.

https://doi.org/10.1182/blood-2019-127344

Published: 2019

Journal Articles

Lymphatic Control of the Tumor Immune Microenvironment

Melody A. Swartz, PhD

Blood (2019) 134 (Supplement_1): SCI-46.

https://doi.org/10.1182/blood-2019-123389

Published: 2019

Journal Articles

Association of Genetic Factors with Long-Term Outcome in Refractory r/r B-ALL Patients after CAR T-Cell Therapy

Jing PAN, Xu Xiuwen, Guo Huilin, Zhuojun Ling, Song Weiliang, Jinlong Xu, Jiajia Duan, Junhan Yang, Zelin Wang, Alex Hong Chang, Qinglong Zheng

Blood (2019) 134 (Supplement_1): 750.

https://doi.org/10.1182/blood-2019-121836

Published: 2019

Journal Articles

An in Vitro Study on the Role of Angiogenesis in Iron Deficiency Induced Reactive Thrombocytosis

Pedro De Alarcon, MD, Manu Gnanamony, PhD, Jessica Garcia, MD

Blood (2018) 132 (Supplement 1): 2450.

https://doi.org/10.1182/blood-2018-99-115378

Published: 2018

Journal Articles

Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

Matias Autio, Suvi-Katri Leivonen, PhD, Judit Mészáros Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Harald Holte, Sirpa Leppa, MD

Blood (2017) 130 (Supplement 1): 4008.

https://doi.org/10.1182/blood.V130.Suppl_1.4008.4008

Published: 2017

Journal Articles

Inhibition of MDR1 Overcomes Brentuximab Vedotin Resistance in Hodgkin Lymphoma Cell Line Model and Is Synergistic with Brentuximab Vedotin in Mouse Xenograft Model

Robert W Chen, MD, Jessie Hou, MS, Indu Nair, Jun Wu, PhD, Tim Synold, Larry W. Kwak, MD, Steven T. Rosen, MD, Stephen J. Forman, MD, Susan Kane, PhD, Edward Newman, PharmD

Blood (2016) 128 (22): 752.

https://doi.org/10.1182/blood.V128.22.752.752

Published: 2016

Journal Articles

FLT4 Expressing CD34 + CD38 - Leukemic Stem Cells in Bone Marrow of Refractory Patients are Protected by Receptor Internalization under Abundant VEGF-C Condition

Ji Yoon Lee, Sung-Eun Lee, A-Reum Han, Hee-Sun Hwang, Woo-Sung Min, Heeje Kim

Blood (2016) 128 (22): 1669.

https://doi.org/10.1182/blood.V128.22.1669.1669

Published: 2016

Journal Articles

Clinical Impact of Different Levels of VEGF-C on Leukemic Blasts in the Bone Marrow and Peripheral Blood of Acute Myeloid Leukemia

Sung-Eun Lee, Ji Yoon Lee, A-Reum Han, Woo-Sung Min, Heeje Kim

Blood (2016) 128 (22): 1670.

https://doi.org/10.1182/blood.V128.22.1670.1670

Published: 2016

Journal Articles

Increased Levels of Endothelial Dysfunction Markers and Matrix Metalloproteinases in Patients with Severe Post-Thrombotic Syndrome

Luis Fernando Bittar, PhD, Fernanda Andrade Orsi, MD PhD, Kiara Cristina Senger Zapponi, MSc, Bruna Moraes Mazetto, PhD, Erich Vinicius De Paula, Sr., MD PhD, Joyce Maria Annichino-Bizzacchi, MD PhD

Blood (2016) 128 (22): 276.

https://doi.org/10.1182/blood.V128.22.276.276

Published: 2016

Journal Articles

Critical requirement of VEGF-C in transition to fetal erythropoiesis

Shentong Fang, Harri Nurmi, Krista Heinolainen, Shuo Chen, Essi Salminen, Pipsa Saharinen, Hanna K. A. Mikkola, Kari Alitalo

Blood (2016) 128 (5): 710–720.

https://doi.org/10.1182/blood-2015-12-687970

Published: 2016

Includes: Supplemental data

Journal Articles

P300 Acetylates STAT3 and Increases Its Constitutive Transcriptional Activity in CLL Cells

Uri Rozovski, MD, David M. Harris, Ping LI, PhD, Zhiming Liu, Alessandra Ferrajoli, MD, Jan A Burger, MD PhD, Philip Thompson, MBBS, Nitin Jain, MD, William Wierda, MD PhD, Michael Keating, MBBS, Zeev Estrov, MD

Blood (2015) 126 (23): 4143.

https://doi.org/10.1182/blood.V126.23.4143.4143

Published: 2015

Journal Articles

The Role of Tumor Associated Macrophages in Multiple Myeloma and Its Pathophysiological Effect on Myeloma Cells Survival, Apopotosis and Angiogenesis

Yu Wu, MD PhD, Xinyi Chen, Yuhuan Zheng

Blood (2015) 126 (23): 4204.

https://doi.org/10.1182/blood.V126.23.4204.4204

Published: 2015

Journal Articles

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Shernan G. Holtan, MD, Michael R. Verneris, MD, Kirk R. Schultz, MD, Laura Newell, MD, Gabrielle Meyers, MD, Fiona C. He, MD, Todd E. DeFor, MS, Margaret L. MacMillan, MD, Sarah A. Cooley, MD MS, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 2489.

https://doi.org/10.1182/blood.V124.21.2489.2489

Published: 2014

Journal Articles

ETS Transcription Factor Etsrp/Etv2 Is Required for Lymphangiogenesis in Zebrafish and Is a Potential Therapeutic Target in Lymphatic Disease

Jennifer A. Davis, DO, Sharina Palencia Desai, PhD, Saulius Sumanas, PhD

Blood (2014) 124 (21): 2767.

https://doi.org/10.1182/blood.V124.21.2767.2767

Published: 2014

Journal Articles

p53 Suppression Mediates Blasts Survival, Proliferation and CD34 Maintenance in Pediatric Acute Myeloid Leukemia

Kim R. Kampen, Frank J.G. Scherpen, Steven M. Kornblau, MD, Evelina SJM de Bont, MD PhD

Blood (2014) 124 (21): 897.

https://doi.org/10.1182/blood.V124.21.897.897

Published: 2014

Journal Articles

Hemogenic Endothelium-like Changes Were Derived to an Adult Human Dermal Fibroblast By Electrical Stimulation

Takuji Matsuo, MD, Ryosuke Shirasaki, MD PhD, Oka Yoko, MD, PhD, Tadashi Yamamoto, MD, Jun Ooi, MD, Kennsuke Matsumoto, MD, PhD, Naoki Shirafuji, MDPhD

Blood (2014) 124 (21): 5129.

https://doi.org/10.1182/blood.V124.21.5129.5129

Published: 2014

Journal Articles

Pressing the right buttons: signaling in lymphangiogenesis

Sanja Coso, Esther Bovay, Tatiana V. Petrova

Blood (2014) 123 (17): 2614–2624.

https://doi.org/10.1182/blood-2013-12-297317

Published: 2014

Journal Articles

Follicular Dendrytic Cells Deliver Angiogenesis Signaling To Follicular Lymphoma Cells That Is Hampered By The Pan-PI3K Inhibitor NVP-BKM120

Alba Matas-Céspedes, MS, Vanina Rodriguez, Susana Kalko, PhD, Eva Gine, MD, PhD, Elias Campo, MD, PhD, Gael Roue, PhD, Armando Lopez-Guillermo, MD, PhD, Dolors Colomer, PhD, Perez-Galan Patricia, PhD

Blood (2013) 122 (21): 3072.

https://doi.org/10.1182/blood.V122.21.3072.3072

Published: 2013

Journal Articles

Clinical Relevance Of VEGF-C/VEGF-D/VEGFR-3 Axis In Diffuse Large B-Cell Lymphoma

Dariusz Wolowiec, Anna Wosztyl, MD, PhD, Ewelina Ziolkowska, MSc, Ewa Robak, Marcin Pasiarski, MD, PhD, Tadeusz Robak, Anna Korycka-Wolowiec

Blood (2013) 122 (21): 5060.

https://doi.org/10.1182/blood.V122.21.5060.5060

Published: 2013

NARROW

Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC

Pomalidomide Reduces Bleeding and Alters Expression of Angiogenesis-Related Proteins in Patients with Hereditary Hemorrhagic Telangiectasia

Lymphatic Control of the Tumor Immune Microenvironment

Association of Genetic Factors with Long-Term Outcome in Refractory r/r B-ALL Patients after CAR T-Cell Therapy

An in Vitro Study on the Role of Angiogenesis in Iron Deficiency Induced Reactive Thrombocytosis

Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

Inhibition of MDR1 Overcomes Brentuximab Vedotin Resistance in Hodgkin Lymphoma Cell Line Model and Is Synergistic with Brentuximab Vedotin in Mouse Xenograft Model

FLT4 Expressing CD34 + CD38 - Leukemic Stem Cells in Bone Marrow of Refractory Patients are Protected by Receptor Internalization under Abundant VEGF-C Condition

Clinical Impact of Different Levels of VEGF-C on Leukemic Blasts in the Bone Marrow and Peripheral Blood of Acute Myeloid Leukemia

Increased Levels of Endothelial Dysfunction Markers and Matrix Metalloproteinases in Patients with Severe Post-Thrombotic Syndrome

Critical requirement of VEGF-C in transition to fetal erythropoiesis

P300 Acetylates STAT3 and Increases Its Constitutive Transcriptional Activity in CLL Cells

The Role of Tumor Associated Macrophages in Multiple Myeloma and Its Pathophysiological Effect on Myeloma Cells Survival, Apopotosis and Angiogenesis

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

ETS Transcription Factor Etsrp/Etv2 Is Required for Lymphangiogenesis in Zebrafish and Is a Potential Therapeutic Target in Lymphatic Disease

p53 Suppression Mediates Blasts Survival, Proliferation and CD34 Maintenance in Pediatric Acute Myeloid Leukemia

Hemogenic Endothelium-like Changes Were Derived to an Adult Human Dermal Fibroblast By Electrical Stimulation

Pressing the right buttons: signaling in lymphangiogenesis

Follicular Dendrytic Cells Deliver Angiogenesis Signaling To Follicular Lymphoma Cells That Is Hampered By The Pan-PI3K Inhibitor NVP-BKM120

Clinical Relevance Of VEGF-C/VEGF-D/VEGFR-3 Axis In Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only